vs

Side-by-side financial comparison of Dolphin Entertainment, Inc. (DLPN) and SUTRO BIOPHARMA, INC. (STRO). Click either name above to swap in a different company.

Dolphin Entertainment, Inc. is the larger business by last-quarter revenue ($15.6M vs $11.6M, roughly 1.3× SUTRO BIOPHARMA, INC.). On growth, Dolphin Entertainment, Inc. posted the faster year-over-year revenue change (27.0% vs -21.4%). Over the past eight quarters, Dolphin Entertainment, Inc.'s revenue compounded faster (1.3% CAGR vs -5.4%).

Dolphin Entertainment, Inc. is an American entertainment marketing and production company based in Coral Gables, Florida. Founded in 1996 by Bill O'Dowd, the company produces television series and films aimed primarily at children and young adults, and owns public relations and marketing firms through acquisitions. Dolphin has also expanded into digital media, including non-fungible token (NFT) ventures and influencer marketing.

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...

DLPN vs STRO — Head-to-Head

Bigger by revenue
DLPN
DLPN
1.3× larger
DLPN
$15.6M
$11.6M
STRO
Growing faster (revenue YoY)
DLPN
DLPN
+48.4% gap
DLPN
27.0%
-21.4%
STRO
Faster 2-yr revenue CAGR
DLPN
DLPN
Annualised
DLPN
1.3%
-5.4%
STRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DLPN
DLPN
STRO
STRO
Revenue
$15.6M
$11.6M
Net Profit
$1.0M
Gross Margin
96.6%
Operating Margin
9.5%
Net Margin
6.5%
Revenue YoY
27.0%
-21.4%
Net Profit YoY
152.0%
35.4%
EPS (diluted)
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLPN
DLPN
STRO
STRO
Q4 25
$15.6M
$11.6M
Q3 25
$14.8M
$9.7M
Q2 25
$14.1M
$63.7M
Q1 25
$12.2M
$17.4M
Q4 24
$12.3M
$14.8M
Q3 24
$12.7M
$8.5M
Q2 24
$11.4M
$25.7M
Q1 24
$15.2M
$13.0M
Net Profit
DLPN
DLPN
STRO
STRO
Q4 25
$1.0M
Q3 25
$-365.5K
$-56.9M
Q2 25
$-1.4M
$-11.5M
Q1 25
$-2.3M
$-76.0M
Q4 24
$-2.0M
$-72.4M
Q3 24
$-8.7M
$-48.8M
Q2 24
$-1.6M
$-48.0M
Q1 24
$-326.8K
$-58.2M
Gross Margin
DLPN
DLPN
STRO
STRO
Q4 25
96.6%
Q3 25
95.6%
Q2 25
94.7%
Q1 25
97.2%
Q4 24
96.1%
Q3 24
98.0%
Q2 24
98.1%
Q1 24
84.8%
Operating Margin
DLPN
DLPN
STRO
STRO
Q4 25
9.5%
Q3 25
2.1%
-499.9%
Q2 25
-0.4%
-5.2%
Q1 25
-14.6%
-393.8%
Q4 24
-11.2%
-440.7%
Q3 24
-64.3%
-797.2%
Q2 24
-9.8%
-189.4%
Q1 24
1.1%
-435.0%
Net Margin
DLPN
DLPN
STRO
STRO
Q4 25
6.5%
Q3 25
-2.5%
-586.6%
Q2 25
-10.0%
-18.0%
Q1 25
-19.1%
-436.6%
Q4 24
-15.9%
-489.2%
Q3 24
-68.5%
-572.6%
Q2 24
-14.2%
-186.8%
Q1 24
-2.1%
-447.5%
EPS (diluted)
DLPN
DLPN
STRO
STRO
Q4 25
$0.10
Q3 25
$-0.03
$-0.67
Q2 25
$-0.13
$-0.14
Q1 25
$-0.21
$-0.91
Q4 24
$-0.21
$-27.63
Q3 24
$-0.80
$-0.59
Q2 24
$-0.17
$-0.59
Q1 24
$-0.04
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLPN
DLPN
STRO
STRO
Cash + ST InvestmentsLiquidity on hand
$8.8M
$141.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$9.7M
$-132.5M
Total Assets
$58.3M
$173.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLPN
DLPN
STRO
STRO
Q4 25
$8.8M
$141.4M
Q3 25
$7.8M
$167.6M
Q2 25
$8.7M
$205.1M
Q1 25
$7.1M
$249.0M
Q4 24
$8.2M
$316.9M
Q3 24
$5.7M
$388.3M
Q2 24
$8.7M
$375.6M
Q1 24
$6.4M
$267.6M
Stockholders' Equity
DLPN
DLPN
STRO
STRO
Q4 25
$9.7M
$-132.5M
Q3 25
$8.4M
$-87.3M
Q2 25
$7.9M
$-32.1M
Q1 25
$9.3M
$-25.8M
Q4 24
$11.6M
$44.6M
Q3 24
$13.6M
$111.2M
Q2 24
$20.4M
$152.2M
Q1 24
$20.3M
$98.0M
Total Assets
DLPN
DLPN
STRO
STRO
Q4 25
$58.3M
$173.8M
Q3 25
$60.0M
$209.7M
Q2 25
$58.6M
$262.4M
Q1 25
$58.6M
$321.4M
Q4 24
$58.4M
$387.2M
Q3 24
$57.3M
$451.8M
Q2 24
$65.6M
$489.0M
Q1 24
$65.1M
$403.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLPN
DLPN
STRO
STRO
Operating Cash FlowLast quarter
$576.6K
$-177.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.57×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLPN
DLPN
STRO
STRO
Q4 25
$576.6K
$-177.2M
Q3 25
$-2.4M
$-38.2M
Q2 25
$1.5M
$-44.7M
Q1 25
$-1.7M
$-67.9M
Q4 24
$850.2K
$-71.7M
Q3 24
$-1.7M
$-64.5M
Q2 24
$1.8M
$9.5M
Q1 24
$-1.2M
$-64.7M
Free Cash Flow
DLPN
DLPN
STRO
STRO
Q4 25
Q3 25
$-2.4M
Q2 25
Q1 25
$-1.7M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
DLPN
DLPN
STRO
STRO
Q4 25
Q3 25
-16.3%
Q2 25
Q1 25
-14.0%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
DLPN
DLPN
STRO
STRO
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
DLPN
DLPN
STRO
STRO
Q4 25
0.57×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons